Azad Abul K, Rajaram Murugesan V S, Schlesinger Larry S
Center for Microbial Interface Biology and the Department of Microbial Infection and Immunity, The Ohio State University, USA.
J Cytol Mol Biol. 2014 Jan 10;1(1). doi: 10.13188/2325-4653.1000003.
The macrophage mannose receptor (MR, CD206) is a C-type lectin expressed predominantly by most tissue macrophages, dendritic cells and specific lymphatic or endothelial cells. It functions in endocytosis and phagocytosis, and plays an important role in immune homeostasis by scavenging unwanted mannoglycoproteins. More attention is being paid to its particularly high expression in tissue pathology sites during disease such the tumor microenvironment. The MR recognizes a variety of microorganisms by their mannan-coated cell wall, which is exploited by adapted intracellular pathogens such as , for their own survival. Despite the continued development of drug delivery technologies, the targeting of agents to immune cells, especially macrophages, for effective diagnosis and treatment of chronic infectious diseases has not been addressed adequately. In this regard, strategies that optimize MR-mediated uptake by macrophages in target tissues during infection are becoming an attractive approach. We review important progress in this area.
巨噬细胞甘露糖受体(MR,CD206)是一种C型凝集素,主要由大多数组织巨噬细胞、树突状细胞以及特定的淋巴管或内皮细胞表达。它在胞吞作用和吞噬作用中发挥作用,并通过清除不需要的甘露糖糖蛋白在免疫稳态中起重要作用。人们越来越关注其在疾病(如肿瘤微环境)的组织病理部位的特别高表达。MR通过其被甘露聚糖包被的细胞壁识别多种微生物,一些适应性细胞内病原体(如……)利用这一点来实现自身存活。尽管药物递送技术不断发展,但将药物靶向免疫细胞,尤其是巨噬细胞,以有效诊断和治疗慢性传染病的问题尚未得到充分解决。在这方面,优化感染期间巨噬细胞对靶组织中MR介导的摄取的策略正成为一种有吸引力的方法。我们综述了该领域的重要进展。